Comparing the effects of dry needling of ankle plantar flexor muscles on neuromodulation, spasticity, and balance in people with MS and stroke.

Not Applicable

Recruiting

• Conditions: Condition 1: Multiple Sclerosis (Remitting Relapsing). Condition 2: Stroke.; Multiple sclerosis; Cerebellar stroke syndrome; G46.4

• Registration Number: IRCT20230206057343N1
• Lead Sponsor: Tehran University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 13 March 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 20

Inclusion Criteria

Remitting and relapsing Multiple sclerosis disease
Having a stroke
EDSS score less than 4 in the group of MS patients
Follow instructions
Spasticity of plantarflexors is equal to or greater than 1 using (MMAS scale)
No diabetes
Absence of any history of treatment with nerve blockers, or treatment with botulinum toxin A 6 months before entering the study.
No history of attacks in MS patients in the last 8 weeks
Absence of limitation of passive range of motion of more than 10 percent in ankle dorsiflexion compared to the less involved leg (absence of contracture).
Absence of other neurological disorder

Exclusion Criteria

Fear of dry needling
Recurrent stroke during the patient evaluation and intervention program
Occurrence of a new attack in a patient with MS
Contraindications to the use of TMS

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
euromodulation. Timepoint: Before the intervention, After 3 sessions of intervention, and 2 weeks after for follow up. Method of measurement: With Trans-cranial magnetic stimulation parameters, Including motor evoked potential (MEP) amplitude at rest and muscle motor threshold at rest (RMT) and motor evoked potential amplitude ratio in intracortical inhibition protocol (SICI) and motor evoked potential amplitude ratio in intracortical facilitation protocol (ICF).;Spasticity. Timepoint: Before the intervention, after 3 sessions of intervention sessions, and two weeks after the last intervention session for follow-up. Method of measurement: Modified Modified Ashworth Scale.

Secondary Outcome Measures

Name	Time	Method
Functional Balance. Timepoint: Before the intervention, after 3 sessions of intervention sessions, and two weeks after the last intervention session for follow-up. Method of measurement: Timed up and go test and Four Square Step test.;Active and Passive ankle dorsiflexion ROM. Timepoint: Before the intervention, after 3 sessions of intervention sessions, and two weeks after the last intervention session for follow-up. Method of measurement: The evaluation will be done using a goniometry.